Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is one of the most groundbreaking advances in cancer treatment in recent decades. Unlike conventional chemotherapy, which is delivered through the bloodstream and affects the entire body, HIPEC specifically targets the abdominal cavity where certain cancers spread. This innovative approach combines surgery with heated chemotherapy, offering hope to patients who were once considered untreatable.

So, what makes HIPEC different? After surgeons remove all visible tumors from the abdomen through a procedure called cytoreductive surgery (CRS), a heated chemotherapy solution is circulated inside the abdominal cavity. The heat enhances the effectiveness of the drugs while minimizing damage to the rest of the body. Think of it as a one-two punch: surgery clears the big tumors, and HIPEC eliminates the microscopic cancer cells left behind.

HIPEC has evolved since the 1980s, when early pioneers experimented with heated chemotherapy to improve survival in peritoneal cancers. Today, it is performed in specialized cancer centers worldwide and is recognized as a potential life-saving therapy for conditions once thought incurable, such as colorectal cancer with peritoneal metastases, ovarian cancer, gastric cancer, and peritoneal mesothelioma.

What truly sets HIPEC apart is its ability to deliver high-dose chemotherapy directly where cancer cells are hiding—inside the peritoneal cavity—without exposing the rest of the body to the same toxic effects. Patients often tolerate HIPEC better than systemic chemotherapy, with improved outcomes and, in many cases, longer survival.

In the sections ahead, we’ll explore the science, procedure, benefits, risks, and future of HIPEC, giving you a complete understanding of this revolutionary treatment.

---

Understanding the Science Behind HIPEC

To appreciate how HIPEC works, we need to understand the two main elements that make it powerful: heat and direct chemotherapy delivery.

1. Role of Heat in Cancer Therapy:
Heat, when used at therapeutic levels (41–43°C), weakens cancer cells, making them more vulnerable to chemotherapy. It disrupts their DNA repair mechanisms, alters protein structures, and damages the cell membranes. Normal healthy cells, however, are more resistant to heat, which creates a therapeutic window where cancer cells are selectively targeted.

2. How Intraperitoneal Chemotherapy Works:
When chemotherapy drugs are introduced into the peritoneal cavity, they come into direct contact with the surfaces of abdominal organs where cancer cells may be hiding. Because the drugs are confined to the abdominal cavity, doctors can use much higher concentrations than would be safe intravenously. This ensures that the drug is strongest exactly where it is needed.

3. The Synergy of Heat and Chemotherapy:
When combined, heat increases blood flow in the peritoneal surfaces, allowing chemotherapy to penetrate deeper into tissues. It also speeds up chemical reactions, enhancing the killing power of the drugs. Think of it like applying heat to open pores before applying medicine—it allows for better absorption and effect.

Together, these factors explain why HIPEC is more effective against microscopic cancer deposits than systemic chemotherapy alone. It directly addresses the unique biology of peritoneal spread, where cancer cells blanket the abdominal cavity rather than forming isolated tumors.